BAM-15
Moderates ForschungsinteresseMitochondrial Uncoupler | Metabolic Enhancer
BAM-15 is a synthetic mitochondrial uncoupler that has emerged as a promising research compound for obesity and metabolic disorders.
Molekulare und Forschungsdaten
- Sequenz
- C16H10F2N6O
- Molekulargewicht
- 326.28 Da
- Halbwertszeit
- ~1.7 hours
- Primäre Ziele
- ampk
- Wege (Forschung)
- oral
- Lagerung
- Room temperature, protect from light and moisture
Overview
BAM-15 is a synthetic mitochondrial uncoupler that has emerged as a promising research compound for obesity and metabolic disorders. Unlike traditional uncouplers like DNP which have serious toxicity concerns, BAM-15 demonstrates a superior safety profile while effectively increasing energy expenditure and fat oxidation. Research in mice shows BAM-15 reduces body fat without affecting food intake, lean mass, or body temperature. It is approximately 7-fold more potent than DNP and does not induce the dangerous hyperthermia associated with older uncouplers. Note: BAM-15 is a small molecule compound, not a peptide, but is commonly sold alongside peptide products.
Mechanism of action
BAM-15 targets the inner mitochondrial membrane, enhancing proton permeability and dissipating the proton gradient. This uncouples electron transport from ATP synthesis, forcing mitochondria to increase respiration and burn more substrates (particularly fat) to maintain energy production. BAM-15 activates AMP-activated protein kinase (AMPK) in response to ATP depletion, promoting glucose uptake and fatty acid oxidation. It also activates PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), enhancing mitochondrial biogenesis. Unlike DNP or FCCP, BAM-15 does not depolarize plasma membranes or induce apoptosis at effective concentrations, explaining its improved safety profile.
Key research findings
- Increases fat oxidation without affecting food intake
- Reduces body fat mass in research models
- 7-fold more potent than DNP with better safety
- Does not cause dangerous hyperthermia
- No effect on lean body mass
- Improves insulin sensitivity
- Orally bioavailable
- Activates AMPK and PGC-1α pathways
- Synergistic with GLP-1 agonists (semaglutide)
Research applications
Metabolic Research
- Obesity/Fat Loss — Reduces body fat by increasing energy expenditure and fat oxidation without reducing food intake.
- Insulin Resistance — Research shows reversal of diet-induced insulin resistance in mouse models.
- Metabolic Syndrome — Addresses multiple components of metabolic syndrome through enhanced energy expenditure.
Combination Therapy Research
- With Semaglutide/GLP-1 Agonists — 2024 research shows combining BAM-15 with semaglutide produces stronger metabolic benefits than either alone by countering metabolic adaptation.
- Caloric Restriction Enhancement — May help overcome weight loss plateaus by preventing metabolic adaptation/efficiency.
Other Research Areas
- Liver Triglycerides — Research shows decreased liver triglycerides in treated animals.
- Glucose Tolerance — Improved glucose tolerance observed in research models.
BAM-15 Häufig gestellte Fragen
How does BAM-15 avoid the dangerous hyperthermia of DNP?+
BAM-15 is approximately 7-fold more potent than DNP but does not induce the dangerous, uncontrollable hyperthermia DNP causes. BAM-15 enhances mitochondrial proton permeability selectively without depolarizing plasma membranes or triggering systemic heat production. It activates compensatory AMPK and PGC-1α pathways instead of creating metabolic chaos.
Can BAM-15 cause fat loss without diet and exercise?+
Research in mice showed BAM-15 reduced body fat without affecting food intake or body temperature, but those were sedentary rodents. Human efficacy requires unclear interaction with actual behavior, diet, and exercise. Results are likely enhanced by caloric deficit and training, not achieved passively.
Why does 2024 research show BAM-15 works better with semaglutide?+
Combining BAM-15 (mitochondrial uncoupler) with semaglutide (GLP-1 agonist) produces stronger metabolic benefits than either alone by countering metabolic adaptation. Semaglutide's appetite suppression plateaus as the body adapts; BAM-15's energy expenditure boost prevents this adaptation, allowing sustained weight loss.
Is BAM-15 safer than other mitochondrial uncouplers like FCCP?+
Yes. Unlike FCCP and traditional uncouplers like DNP, BAM-15 does not depolarize plasma membranes or induce apoptosis at effective doses. This selective mitochondrial targeting makes it substantially safer, though human safety data remains limited. It's still a research chemical without FDA approval.
References
- [1]Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in miceNature Communications
- [2]BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic controlEMBO Molecular Medicine
- [3]BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseasesPMC Review
- [4]Beneficial effects of simultaneously targeting calorie intake and calorie efficiency in diet-induced obese miceClinical Science
Verwandte Peptide
5-Amino-1MQ
PreclinicalNNMT Inhibitor | Longevity & Metabolic Enhancement
5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that enhances cellular NAD+ levels and mitochondrial function.
AOD-9604
Well studiedModified hGH Fragment | Fat Loss Peptide
AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits lipogenesis without the side effects of full growth hormone.
Cagrilintide
Extensively studiedLong-Acting Amylin Receptor Agonist | Weight Loss & Diabetes
Novel long-acting lipidated amylin analog functioning as dual amylin and calcitonin receptor agonist for weight management and type 2 diabetes.
HGH Fragment 176-191
Moderate researchGrowth Hormone Fragment | Fat Loss Peptide
HGH Fragment 176-191 is the fat-burning segment of human growth hormone, corresponding to amino acids 176 through 191 of the full GH molecule.